Shareholder alert: rigrodsky law, p.a. is investigating checkmate pharmaceuticals, inc. buyout

Wilmington, delaware--(newsfile corp. - april 20, 2022) - rigrodsky law, p.a. is investigating checkmate pharmaceuticals, inc. ("checkmate") (nasdaq: cmpi) regarding possible breaches of fiduciary duties and other violations of law related to checkmate's agreement to be acquired by regeneron pharmaceuticals, inc. (nasdaq: regn). under the terms of the agreement, checkmate's shareholders will receive $10.50 in cash for each share of checkmate common stock they own.to learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-checkmate-pharmaceuticals-inc.to...
REGN Ratings Summary
REGN Quant Ranking